- Title
- PD32-03 A PHASE 2 OPEN-LABEL TRIAL OF GTX-758 IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER, FINAL ANALYSIS OF THE PRIMARY ENDPOINT
- Creators
- William Aronson - Canadian Urological AssociationEvan Yu - AstraZeneca (United States)Michael Hancock - AstraZeneca (United States)Tamás Babicz - Canadian Urological AssociationRonald Tutrone - AstraZeneca (United States)Christopher Ng - Canadian Urological AssociationLaurence Belkoff - AstraZeneca (United States)Zsuzsanna Pápai - Canadian Urological AssociationLajos Géczi - Canadian Urological AssociationRobert Getzenberg - Canadian Urological Association
- Publication Details
- The Journal of urology, v 195(4S), pp e761-e762
- Publisher
- ELSEVIER SCIENCE INC; NEW YORK
- Number of pages
- 2
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Surgery
- Web of Science ID
- WOS:000375539500372
- Other Identifier
- 991021916911704721
Abstract
PD32-03 A PHASE 2 OPEN-LABEL TRIAL OF GTX-758 IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER, FINAL ANALYSIS OF THE PRIMARY ENDPOINT
The Journal of urology, v 195(4S), pp e761-e762
Apr 2016
Metrics
2 Record Views
Details
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Urology & Nephrology